A study leveraging deep gray matter atrophy and dopamine availability imaging identified distinct clinical subtypes of early Parkinson’s disease. The subtypes correlate with specific phenotypic features and motor symptom severity, enhancing understanding of disease heterogeneity. These findings could inform precision medicine approaches and targeted interventions in Parkinson’s, advancing biomarker development and clinical management.